Lana Feng, Ph.D.

Lana Feng, Ph.D. has extensive experience in the life sciences and biotechnology industries. Lana is the Co-founder and CEO of Huma.AI, a leading generative AI solution for life sciences. Lana collaborated with OpenAI to train GPT models specifically for life sciences, ensuring privacy, security, accuracy, and traceability. The platform has been validated and deployed by multiple clients.

Before Huma.AI, Lana was the Founder and CEO of Personalized Diagnostics, Inc. where they developed multiple diagnostic products for early cancer detection. Lana also facilitated a $38 million US/China cross-border deal for precision medicine diagnostics and brokered multiple China entry deals for US companies in cancer diagnostics, novel drug development, and digital pathology.

Lana also served as the Co-Chairman of the Pacific Forum at the Sino-American Biotechnology and Pharmaceutical Professionals Association (SABPA), organizing conferences that brought biotech professionals and investors together across the Pacific.

Prior to that, Lana worked at Novartis Oncology Business Unit as an Associate Director of Business Development, where they built Asian partnerships for CDx and provided oncology biomarker support for clinical trials and companion diagnostics development.

Lana also held positions at Genoptix, Inc. as Associate Director of BioPharma Business, where they successfully built a biopharma business from scratch and played a pivotal role in Novartis' acquisition of Genoptix.

Earlier in their career, Lana worked at GeneOhm (acquired by BD) as the Scientific Affairs and Technical Services Lead, overseeing the commercialization of FDA-cleared infectious disease products. Lana also worked at Nanogen as a Staff Scientist and Applications Lab Manager and completed their post-doc fellowship at UCSD.

Overall, Lana Feng, Ph.D. has a strong background in business development, diagnostics, and cross-border deals in the life sciences industry.

Lana Feng, Ph.D. has an extensive education background in the field of Molecular, Cellular, and Developmental Biology. Lana obtained their Ph.D. from Northwestern University - The Feinberg School of Medicine from 1988 to 1991. Following that, Lana pursued further research and education by completing another Ph.D. program at Indiana University Bloomington from 1991 to 1994. Subsequently, they engaged in post-doctoral research at the University of California, San Diego - School of Medicine from 1994 to 1997. Prior to their Ph.D. studies, it is known that Lana attended Wuhan University, although specific details about their degree or field of study are unavailable.